On September 30, 2014, Health Canada issued an import ban on medications and drug ingredients from three factories in India – you can learn more here.


InnoviCares was featured in The Globe & Mail's Special Report on The Future of Prescription Drugs as a program that empowers patient choice and a solution for benefit plan sustainability. The editorial includes interviews with patients, physicians, patient advocates and STI Technologies Limited's (innoviCares parent company) CEO, Steve Nicolle. To view the PDF of the article, click on the image below.


With the increase in media attention surrounding the pharmaceutical industry in Canada (such as the recent article in the Toronto Star) we would like to remind you that we are proud to offer you greater access and choice by paying all, or part of, the difference in price between nearly 100 well-known brand-name med


The innoviCares Terms & Conditions  and the corporate STI Technologies Limited Privacy Policy have been updated as of today. These updates will go into effect immediately, and by continuing to use innoviCares and it’s online properties, you agree to these revised documents.    


On May 12, 2014, innoviCares will publish an updated version of its Terms & Conditions and the corporate STI Technologies Limited Privacy Policy.  


InnoviCares has launched a great new iPhone app for innoviCares that puts a digital, interactive version of your innoviCares card in your pocket. Managing your healthcare has never been easier with the help of the unique features on the app.

Learn more or download it at the iTunes storetoday.